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‘Radio-guided occult lesion localization’ is a new technique in the breast conservative surgery performed
for the localization and resection of non-palpable breast lesions.
The purpose of this study is to evaluate the results of this breast surgical procedure provided by several
published papers.
 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Widespread mammography screening programs and recent
technological advances in breast ultrasound have resulted in an
increased detection of breast non-palpable lesions. Breast cancer is
the most frequent malignancy in women and to date, detection of
asymptomatic tumors is the best way to reduce mortality for this
malignancy. Non-palpable lesions represent up to 25% of breast
lesions detected by mammogram or ultrasonography. Radiological
signs of non-palpable lesions are most commonly represented by
clusters of microcalciﬁcations and/or parenchymal distorsions.1
To perform breast conserving surgery in these patients, the
tumor needs to be localized correctly before surgical excision.
Radio-guided occult lesion localization (ROLL) is a newapproach
in the localization and resection of non-palpable breast lesions. The
ROLL technique, introduced in 1996, utilizes a radiopharmaceutical
tracer which is injected in the tumor and which is commonly used
for lymphatic mapping and sentinel node biopsies.2 In the same
surgical procedure, the tracer can be used to localize the primary
tumor guided by a gamma probe.
The nuclear radiotracer is generally represented by particles of
human serum albumin ranging between 10 and 150 nm of diam-
eter labeled with 3.7 Mbq of Tc99. The solution of the radiotracer isRovera).
ciates Ltd. Published by Elsevier Ltinjected in the breast lesion under stereotactic or ultrasound
guidance and remains ﬁrmly ﬁxed in the site of injection. On the
same day or the next day, after isotope injection, the excision of the
primary tumor is guided by a gamma probe. The ROLL procedure
can then be performed along with the sentinel node biopsy guided
by a gamma probe using two different isotopic tracers with
different molecular weights: one is injected directly into the lesion
for ROLL and the other is injected into the subdermal layer around
the tumor region for sentinel lymph node detection.
The ROLL procedure permits a precise and accurate localization of
the breast lesion. The tracer is positioned correctly in the 90–99% of
the cases. The exact site of the tumor excision can be checked
constantly during the procedure by using the probe. The boarders of
excision are determined by the review of preoperative imaging and
the site where radioactivity falls off sharply. After complete excision
of the lesion, the gamma probe is used to explore the resection bed,
searching for any residual area of high radioactivity. Further surgical
exploration is performed if the radioactivity count in the resection
bed remains high during the same procedure. If there is an absence
of high radioactivity in the resection tumor bed, thewound is closed.2. Review of literature
A recent review by van der Ploeg et al. selected four clinically
controlled trials of level 2b and one randomized controlled trial of
level 1b, all of modest size, describing both the ROLL and the wire-
guided localization (WGL) procedures. Four articles describing thed. All rights reserved.
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dure were also reviewed.3 One study included both non-palpable
and palpable biopsy proven breast carcinomas. The other studies
included patientswith both suspicious andmalignant breast lesions.
In the ROLL group, between 64% and 84% of the lesions were
radically excised, compared with 44–60% of the lesions in the WGL
group. Two trials revealed a statistically signiﬁcant difference
regarding tumor free margins in favour of the ROLL patients. In the
study conducted by Thind et al., 84% of ROLL patients and 60% of the
WGL patients had tumor free margins (p¼ 0.001).4 Zgajnar et al.
reported that 70% of ROLL and 44% of the WGL patients had clear
surgical margins after a single operation (p¼ 0.005).5 Two studies
indicated a shorter localization time in the ROLL group. Another
study measured the mean surgical difﬁculty and the mean proce-
dure pain. The ROLL procedure scored 2.6 and the WGL method
scored 4.4 out of 10 (p< 0.001), as mean surgical difﬁculty. Mean
pain intensity was reported as 2.7 (during ROLL) and 3.6 out of 10
(during WGL), and the difference was statistically signiﬁcant
(p¼ 0.0012).6 In a clinically controlled trial, the cosmetic result was
qualiﬁed by 73% of the patients as excellent and by 27% of the
patients as good in the ROLL group, whereas in the WGL group the
cosmetic result was qualiﬁed by 54% of the patients as excellent and
by 46% of the patients as good. The studies that took into account
ROLL and the sentinel node procedure showed even higher
percentages of radically excised specimens ranging from 90% to 95%
and an identiﬁcation rate of sentinel lymph nodes of up to 100%.4
A large trial on ROLL published recently by van Rijk et al.
including 368 patients showed tumor free margins in 89% of cases
and a 97% identiﬁcation rate of the sentinel lymph node.7 The
patients in this study were not randomized, and a hook wire was
always inserted at the primary tumor site.
All previously published studies indicate a beneﬁt for the ROLL
procedure, but are not conclusive. The only randomized clinical
trial available lacks essential information on tumor size and free
surgical margins.
In the randomized-prospective study of Medina-Franco, one
hundred consecutive women with non-palpable breast lesions
were randomized to ROLL or WGL.8 The two study groups were
comparable for age, radiological ﬁndings, and type of surgical
procedure. The localization time was signiﬁcantly reduced with
ROLL (p< 0.001). Both techniques resulted in 100% retrieval of the
lesions as conﬁrmed with imaging study of the breast specimen.
Nine patients in the ROLL group versus eight in the WGL group had
a cancer diagnosis. Among cancer patients, in a signiﬁcantly larger
number of ROLL patients, 7/8 (87.5%), compared withWGL patients,
5/8 (62.5%), the lesion was correctly identiﬁed and excised
(p¼ 0.004). The small number of cancer patients in this series
precluded any deﬁnitive conclusion in this regard. Considering
cosmetic results, 76% of ROLL patients had excellent and 24% had
good outcomes, compared to 52% excellent and 48% good outcomes
for the WGL group. This ﬁnding suggests a trend toward a cosmetic
advantage for the ROLL procedure (p¼ 0.005), but a larger series
would be required to validate this result.
In a recent multidisciplinary center, prospective randomized
clinical trial of three hundred and sixteen patients was recruited in
2 years and randomized for either ROLL or WGL.9 All patients were
conﬁrmed to have occult breast cancer and needed to be treated
with a lumpectomy and sentinel node biopsy. Other endpoints
included cosmetic outcome, cost effectiveness, patient discomfort,
and degree of difﬁculty of the procedures.
3. Conclusion
The key point of the ROLL technique is the injection of 99tm
Tc-labeled colloid particles of human serum albumin into thecenter of the suspicious lesion using mammographic guidance
(when only microcalciﬁcations are present) or ultrasonographic
guidance (for palpable complex cysts or masses).
For optimal results, this procedure requires careful communi-
cation and close collaboration among the radiologist, nuclear
medicine specialist and the surgeon.
The ROLL has been shown to be highly effective in the preop-
erative and intraoperative localization of non-palpable breast
lesions as compared with WGL, attaining a reduction in the tradi-
tional technical limitations, such as wire displacement, patient
discomfort and wider excision to permit complete excision.10–17
Regarding the safety of the procedure, the dose absorbed by the
breast and other surrounding tissues are insigniﬁcant because the
injected dose is small and concentrated within the removed tissue.
An important advantage of the ROLL procedure is that the
radiotracer can be used also to detect the sentinel lymph node.
Therefore, it is not necessary to use a separate injection for the
sentinel lymph node detection. Feggi et al. demonstrated success-
fully that it is possible to perform ROLL and sentinel lymph node
mapping with a single injection of Tc-labeled nanocolloid.18
Based on the literature, compared to conventional guide wire
localization, the ROLL technique seems to be faster, more accurate,
more comfortable, provides a better cosmetic result and higher
percentage of tumor freemargins in the case of cancer patients. The
combination of ROLL and the sentinel node biopsy with the use of
a single radiotracer is feasible and efﬁcient. In regards to non-
palpable malignant lesions, ROLL permits accurate excision with
tumor free margins in a high percentage of cases.Conﬂict of interest
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